<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI casecontrol study</title>
				<funder ref="#_YZ3KjTU #_BcD34UD #_6uBNMJS #_QPEtz8M #_d55GMvN #_STpVHcB #_BYsvQNY #_FB3cc6p #_eQ7Y8gC #_UBe9djh #_Ny6FYRT #_kAvshUz">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder>
					<orgName type="full">Cambridge University Press</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2023-05-02">2 May 2023</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Edoardo</forename><surname>Spinazzola</surname></persName>
							<email>edoardo.spinazzola@kcl.ac.uk</email>
						</author>
						<author>
							<persName><forename type="first">Diego</forename><surname>Quattrone</surname></persName>
							<idno type="ORCID">0000-0002-8070-0618</idno>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychosis Studies</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<addrLine>De Crespigny Park Denmark Hill</addrLine>
									<postCode>SE5 8AF</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Child and Adolescent Psychiatry</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution" key="instit1">Hospital General Universitario Gregorio Marañón</orgName>
								<orgName type="institution" key="instit2">Universidad Complutense</orgName>
								<address>
									<addrLine>C/Doctor Esquerdo 46</addrLine>
									<postCode>28007</postCode>
									<settlement>Madrid</settlement>
									<region>IiSGM (CIBERSAM</region>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department</orgName>
								<orgName type="institution" key="instit1">Villa de Vallecas Mental Health</orgName>
								<orgName type="institution" key="instit2">Villa de Vallecas Mental Health Centre</orgName>
								<orgName type="institution" key="instit3">Hospital Universitario Infanta Leonor / Hospital Virgen de la Torre</orgName>
								<address>
									<addrLine>San Claudio 154</addrLine>
									<postCode>28038</postCode>
									<settlement>Madrid</settlement>
									<region>C</region>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Victoria</forename><surname>Rodriguez</surname></persName>
							<idno type="ORCID">0000-0002-6051-8309</idno>
						</author>
						<author>
							<persName><forename type="first">Giulia</forename><surname>Trotta</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychosis Studies</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<addrLine>De Crespigny Park Denmark Hill</addrLine>
									<postCode>SE5 8AF</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Luis</forename><surname>Alameda</surname></persName>
							<idno type="ORCID">0000-0003-2801-9718</idno>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department</orgName>
								<orgName type="department" key="dep2">Centro de Salud Mental Puente de Vallecas</orgName>
								<orgName type="institution" key="instit1">Puente de Vallecas Mental Health</orgName>
								<orgName type="institution" key="instit2">Hospital Universitario Infanta Leonor / Hospital Virgen de la Torre</orgName>
								<orgName type="institution" key="instit3">C/Peña</orgName>
								<address>
									<addrLine>Gorbea 4</addrLine>
									<postCode>28018</postCode>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Fundación Pública Galega de Medicina Xenómica</orgName>
								<orgName type="institution">Hospital Clínico Universitario</orgName>
								<address>
									<addrLine>Choupana s/n</addrLine>
									<postCode>15782</postCode>
									<settlement>Santiago de Compostela</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Giada</forename><surname>Tripoli</surname></persName>
							<idno type="ORCID">0000-0002-8621-2885</idno>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution" key="instit1">Hospital General Universitario Gregorio Marañón</orgName>
								<orgName type="institution" key="instit2">Universidad Complutense</orgName>
								<address>
									<addrLine>IiSGM (CIBERSAM) C/Doctor Esquerdo 46</addrLine>
									<postCode>28007</postCode>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Charlotte</forename><surname>Gayer-Anderson</surname></persName>
							<idno type="ORCID">0000-0002-9257-6677</idno>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)</orgName>
								<orgName type="institution" key="instit1">Hospital Clinic</orgName>
								<orgName type="institution" key="instit2">IDIBAPS</orgName>
								<orgName type="institution" key="instit3">Universidad de Barcelona</orgName>
								<address>
									<addrLine>C/Villarroel 170, escalera 9, planta 6</addrLine>
									<postCode>08036</postCode>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tom</forename><forename type="middle">P</forename><surname>Freeman</surname></persName>
							<idno type="ORCID">0000-0003-1636-889X</idno>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="department" key="dep3">Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)</orgName>
								<orgName type="institution">Universidad de Valencia</orgName>
								<address>
									<addrLine>C/Avda. Blasco Ibáñez 15</addrLine>
									<postCode>46010</postCode>
									<settlement>Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Department of Medicine</orgName>
								<address>
									<addrLine>Psychiatry Area</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Emma</forename><forename type="middle">C</forename><surname>Johnson</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">School of Medicine</orgName>
								<orgName type="department" key="dep2">Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)</orgName>
								<orgName type="institution">Universidad de Oviedo</orgName>
								<address>
									<addrLine>C/Julián Clavería s/n</addrLine>
									<postCode>33006</postCode>
									<settlement>Oviedo</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hannah</forename><forename type="middle">E</forename><surname>Jongsma</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Early Psychosis Section</orgName>
								<orgName type="department" key="dep3">Academic Medical Centre</orgName>
								<orgName type="institution">University of Amsterdam</orgName>
								<address>
									<addrLine>Meibergdreef 5</addrLine>
									<postCode>1105 AZ</postCode>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simona</forename><surname>Stilo</surname></persName>
							<affiliation key="aff13">
								<orgName type="institution">Rivierduinen Centre for Mental Health</orgName>
								<address>
									<addrLine>Sandifortdreef 19</addrLine>
									<postCode>2333 ZZ</postCode>
									<settlement>Leiden Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Caterina</forename><surname>La Cascia</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution" key="instit1">Hospital General Universitario Gregorio Marañón</orgName>
								<orgName type="institution" key="instit2">Universidad Complutense</orgName>
								<address>
									<addrLine>IiSGM (CIBERSAM) C/Doctor Esquerdo 46</addrLine>
									<postCode>28007</postCode>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Laura</forename><surname>Ferraro</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution" key="instit1">Hospital General Universitario Gregorio Marañón</orgName>
								<orgName type="institution" key="instit2">Universidad Complutense</orgName>
								<address>
									<addrLine>IiSGM (CIBERSAM) C/Doctor Esquerdo 46</addrLine>
									<postCode>28007</postCode>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniele</forename><forename type="middle">La</forename><surname>Barbera</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution" key="instit1">Hospital General Universitario Gregorio Marañón</orgName>
								<orgName type="institution" key="instit2">Universidad Complutense</orgName>
								<address>
									<addrLine>IiSGM (CIBERSAM) C/Doctor Esquerdo 46</addrLine>
									<postCode>28007</postCode>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antonio</forename><surname>Lasalvia</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Department of Psychiatry and Neuropsychology</orgName>
								<orgName type="department" key="dep2">School for Mental Health and Neuroscience</orgName>
								<orgName type="institution" key="instit1">South Limburg Mental Health Research and Teaching Network</orgName>
								<orgName type="institution" key="instit2">Maastricht University Medical Centre</orgName>
								<address>
									<addrLine>The Netherlands. 15 AP-HP</addrLine>
									<postBox>P.O. Box 616</postBox>
									<postCode>6200 MD</postCode>
									<settlement>Maastricht</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sarah</forename><surname>Tosato</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Department of Psychiatry and Neuropsychology</orgName>
								<orgName type="department" key="dep2">School for Mental Health and Neuroscience</orgName>
								<orgName type="institution" key="instit1">South Limburg Mental Health Research and Teaching Network</orgName>
								<orgName type="institution" key="instit2">Maastricht University Medical Centre</orgName>
								<address>
									<addrLine>The Netherlands. 15 AP-HP</addrLine>
									<postBox>P.O. Box 616</postBox>
									<postCode>6200 MD</postCode>
									<settlement>Maastricht</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ilaria</forename><surname>Tarricone</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Giuseppe</forename><surname>D'andrea</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Michela</forename><surname>Galatolo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Tortelli</surname></persName>
							<affiliation key="aff16">
								<orgName type="department">Maréchal de Lattre de Tassigny</orgName>
								<orgName type="institution">INSERM</orgName>
								<address>
									<addrLine>Equipe 15 51 Avenue de</addrLine>
									<postCode>U955 94010</postCode>
									<settlement>Créteil</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="department">Faculté de Médecine</orgName>
								<orgName type="institution">Université Paris-Est</orgName>
								<address>
									<addrLine>51 Avenue de Maréchal de Lattre de Tassigny</addrLine>
									<postCode>94010</postCode>
									<settlement>Créteil</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ilaria</forename><surname>Tagliabue</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Fondation Fondamental</orgName>
								<address>
									<addrLine>40 Rue de Mesly</addrLine>
									<postCode>94000</postCode>
									<settlement>Créteil</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="institution">CMP B CHU</orgName>
								<address>
									<addrLine>Cedex 1</addrLine>
									<postBox>BP 69</postBox>
									<postCode>63003</postCode>
									<settlement>Clermont Ferrand</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Turco</surname></persName>
							<affiliation key="aff18">
								<orgName type="institution">Fondation Fondamental</orgName>
								<address>
									<addrLine>40 Rue de Mesly</addrLine>
									<postCode>94000</postCode>
									<settlement>Créteil</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maurizio</forename><surname>Pompili</surname></persName>
							<affiliation key="aff20">
								<orgName type="institution">Université Clermont Auvergne</orgName>
								<address>
									<postCode>7280 63000</postCode>
									<settlement>Clermont-Ferrand</settlement>
									<region>EA</region>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jean-Paul</forename><surname>Selten</surname></persName>
							<affiliation key="aff21">
								<orgName type="institution">Etablissement Public de Santé Maison Blanche</orgName>
								<address>
									<settlement>Paris Barcelona</settlement>
									<country>France Spain;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lieuwe</forename><surname>De Haan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Paulo</forename><forename type="middle">Rossi</forename><surname>Menezes</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Cristina</forename><forename type="middle">M</forename><surname>Del Ben</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jose</forename><forename type="middle">Luis</forename><surname>Santos</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><surname>Arrojo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Julio</forename><surname>Bobes</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Julio</forename><surname>Sanjuán</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Miguel</forename><surname>Bernardo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Celso</forename><surname>Arango</surname></persName>
							<affiliation key="aff22">
								<orgName type="department" key="dep1">Department of Child and Adolescent Psychiatry</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry and Mental Health</orgName>
								<orgName type="department" key="dep3">School of Medicine</orgName>
								<orgName type="institution" key="instit1">Hospital General Universitario Gregorio Marañón</orgName>
								<orgName type="institution" key="instit2">Universidad Complutense</orgName>
								<address>
									<addrLine>IiSGM, CIBERSAM</addrLine>
									<settlement>Madrid</settlement>
									<country>Spain;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">James</forename><forename type="middle">B</forename><surname>Kirkbride</surname></persName>
							<affiliation key="aff23">
								<orgName type="department">Division of Psychiatry</orgName>
								<orgName type="laboratory">Psylife Group</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<settlement>Reader London</settlement>
									<country>UK;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">B</forename><surname>Jones</surname></persName>
							<affiliation key="aff24">
								<orgName type="department">Department of Psychiatry</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country>UK;</country>
								</address>
							</affiliation>
							<affiliation key="aff25">
								<orgName type="department">CAMEO Early Intervention Service</orgName>
								<orgName type="institution">Cambridgeshire &amp; Peterborough NHS Foundation Trust</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country>UK;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>O'donovan</surname></persName>
							<affiliation key="aff26">
								<orgName type="department" key="dep1">Division of Psychological Medicine and Clinical Neurosciences</orgName>
								<orgName type="department" key="dep2">MRC Centre for Neuropsychiatric Genetics and Genomics</orgName>
								<orgName type="institution">Cardiff University</orgName>
								<address>
									<settlement>Cardiff</settlement>
									<country>UK;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bart</forename><forename type="middle">P</forename><surname>Rutten</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jim</forename><surname>Van Os</surname></persName>
							<affiliation key="aff21">
								<orgName type="institution">Etablissement Public de Santé Maison Blanche</orgName>
								<address>
									<settlement>Paris Barcelona</settlement>
									<country>France Spain;</country>
								</address>
							</affiliation>
							<affiliation key="aff27">
								<orgName type="department">Department Psychiatry</orgName>
								<orgName type="institution" key="instit1">Brain Centre Rudolf Magnus</orgName>
								<orgName type="institution" key="instit2">Utrecht University Medical Centre</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country>The Netherlands;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Craig</forename><surname>Morgan</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)</orgName>
								<orgName type="institution" key="instit1">Hospital Clinic</orgName>
								<orgName type="institution" key="instit2">IDIBAPS</orgName>
								<orgName type="institution" key="instit3">Universidad de Barcelona</orgName>
								<address>
									<addrLine>C/Villarroel 170, escalera 9, planta 6</addrLine>
									<postCode>08036</postCode>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pak</forename><forename type="middle">C</forename><surname>Sham</surname></persName>
							<affiliation key="aff28">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">State Key Laboratory of Brain and Cognitive Sciences</orgName>
								<orgName type="department" key="dep3">Li KaShing Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">Centre for PanorOmic Sciences</orgName>
								<orgName type="institution" key="instit2">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Isabelle</forename><surname>Austin-Zimmerman</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychosis Studies</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<addrLine>De Crespigny Park Denmark Hill</addrLine>
									<postCode>SE5 8AF</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhikun</forename><surname>Li</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychosis Studies</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<addrLine>De Crespigny Park Denmark Hill</addrLine>
									<postCode>SE5 8AF</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Evangelos</forename><surname>Vassos</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychosis Studies</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<addrLine>De Crespigny Park Denmark Hill</addrLine>
									<postCode>SE5 8AF</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eu-Gei</forename><forename type="middle">Wp2</forename><surname>Group</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychosis Studies</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<addrLine>De Crespigny Park Denmark Hill</addrLine>
									<postCode>SE5 8AF</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robin</forename><forename type="middle">M</forename><surname>Murray</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marta</forename><forename type="middle">Di</forename><surname>Forti</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Psychosis Studies</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<addrLine>De Crespigny Park Denmark Hill</addrLine>
									<postCode>SE5 8AF</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department</orgName>
								<orgName type="institution" key="instit1">Villa de Vallecas Mental Health</orgName>
								<orgName type="institution" key="instit2">Villa de Vallecas Mental Health Centre</orgName>
								<orgName type="institution" key="instit3">Hospital Universitario Infanta Leonor / Hospital Virgen de la Torre</orgName>
								<address>
									<addrLine>San Claudio 154</addrLine>
									<postCode>28038</postCode>
									<settlement>Madrid</settlement>
									<region>C</region>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Seri</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alexander</forename><surname>Richards</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Aoife</forename><surname>Coghlan</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Health Service and Population Research</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry</orgName>
								<orgName type="institution">Kings College London</orgName>
								<address>
									<addrLine>De Crespigny Park Denmark Hill</addrLine>
									<postCode>SE5 8AF</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">C/Hermandad de Donantes de Sangre</orgName>
								<orgName type="institution">Servicio de Psiquiatría Hospital &quot;Virgen de la Luz&quot;</orgName>
								<address>
									<postCode>16002</postCode>
									<settlement>Cuenca</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="institution">Groupe Hospitalier &quot;Mondor&quot;</orgName>
								<address>
									<addrLine>Pôle de Psychiatrie 51 Avenue de Maréchal de Lattre de Tassigny</addrLine>
									<postCode>94010</postCode>
									<settlement>Créteil</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="department" key="dep1">and 37 Research Foundation</orgName>
								<orgName type="department" key="dep2">Biomedical Research Centre at South London and Maudsley</orgName>
								<orgName type="institution" key="instit1">National Institute for Health Research</orgName>
								<orgName type="institution" key="instit2">NHS Foundation Trust and King&apos;s College London</orgName>
								<orgName type="institution" key="instit3">NIHR BRC at University College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI casecontrol study</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2023-05-02">2 May 2023</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1017/S0033291723001071</idno>
					<note type="submission">Received: 21 September 2022 Revised: 23 January 2023 Accepted: 3 April 2023</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.1" ident="GROBID" when="2025-10-29T00:37+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Cannabis use</term>
					<term>path analysis</term>
					<term>psychotic disorders</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Background. While cannabis use is a well-established risk factor for psychosis, little is known about any association between reasons for first using cannabis (RFUC) and later patterns of use and risk of psychosis. Methods. We used data from 11 sites of the multicentre European Gene-Environment Interaction (EU-GEI) case-control study. 558 first-episode psychosis patients (FEPp) and 567 population controls who had used cannabis and reported their RFUC.We ran logistic regressions to examine whether RFUC were associated with first-episode psychosis (FEP) case-control status. Path analysis then examined the relationship between RFUC, subsequent patterns of cannabis use, and case-control status. Results. Controls (86.1%) and FEPp (75.63%) were most likely to report 'because of friends' as their most common RFUC. However, 20.1% of FEPp compared to 5.8% of controls reported: 'to feel better' as their RFUC (χ 2 = 50.97; p &lt; 0.001). RFUC 'to feel better' was associated with being a FEPp (OR 1.74; 95% CI 1.03-2.95) while RFUC 'with friends' was associated with being a control (OR 0.56; 95% CI 0.37-0.83). The path model indicated an association between RFUC 'to feel better' with heavy cannabis use and with FEPp-control status. Conclusions. Both FEPp and controls usually started using cannabis with their friends, but more patients than controls had begun to use 'to feel better'. People who reported their reason for first using cannabis to 'feel better' were more likely to progress to heavy use and develop a psychotic disorder than those reporting 'because of friends'.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>A meta-analysis including cross-sectional and longitudinal studies has shown that heavy cannabis use is associated with a 4-fold increase in the risk of psychosis <ref type="bibr" target="#b38">(Marconi, Di Forti, Lewis, Murray, &amp; Vassos, 2016)</ref>. Moreover, a higher incidence of psychotic disorders was reported in regions with a higher prevalence of daily use and greater availability of high-potency cannabis <ref type="bibr" target="#b17">(Di Forti et al., 2019)</ref>. The average proportion of delta-9-tetrahydrocannabinol (THC) in the cannabis available in international markets increased from 1970 to 2017 <ref type="bibr" target="#b24">(Freeman et al., 2021)</ref>. Two studies conducted in Denmark found that an increase in the use and potency of cannabis in the population during the past two decades was accompanied by a noticeable increase in the incidence of cannabis-induced psychosis <ref type="bibr" target="#b29">(Hjorthoj, Larsen, Starzer, &amp; Nordentoft, 2021a)</ref>, and a 3-to 4-fold increase in the proportion of cases of schizophrenia associated with cannabis use disorder (CUD) <ref type="bibr" target="#b30">(Hjorthoj, Posselt, &amp; Nordentoft, 2021b)</ref>. Moreover, a recent within-person analysiswhere each participant serves as their controlfound that cannabis is likely to have a causal impact on psychosis, but not the other way around <ref type="bibr" target="#b50">(van Os et al., 2021)</ref>.</p><p>Some argue that the association between cannabis use and psychotic disorders can be explained as an attempt to 'self-medicate' by those who experience sub-clinical psychosis, trying to relieve existing subthreshold psychotic symptoms <ref type="bibr" target="#b32">(Khantzian, 1985)</ref>. However, most studies report that patients with psychosis use cannabis for the same reasons as the general population, such as for the pleasurable effects and social reasons rather than to self-medicate <ref type="bibr" target="#b13">(Dekker, Linszen, &amp; De Haan, 2009;</ref><ref type="bibr" target="#b14">Dekker et al., 2010;</ref><ref type="bibr" target="#b28">Green, Kavanagh, &amp; Young, 2004;</ref><ref type="bibr" target="#b33">Kolliakou, Joseph, Ismail, Atakan, &amp; Murray, 2011;</ref><ref type="bibr" target="#b44">Pérez, Santacana, Baquero, &amp; Pérez-Solà, 2014)</ref>.</p><p>While some studies have examined why people use cannabis and whether the subjective effects of cannabis differ between patients with their first episode of psychosis and controls <ref type="bibr" target="#b10">(Bianconi et al., 2016;</ref><ref type="bibr" target="#b12">Dekker, Koeter, Van Den Brink, &amp; Investigators, 2012;</ref><ref type="bibr" target="#b13">Dekker et al., 2009;</ref><ref type="bibr" target="#b45">Peters et al., 2009)</ref>, an accurate search of the literature (see online supplementary) indicated little evidence on the reasons for the first use of cannabis (RFUC). Moreover, it is not clear if RFUC explains later patterns of use, or if RFUC differs between those who later develop psychosis and healthy controls. This is the first study that uses data from a large multisite firstepisode psychosis (FEP) case-control design and aims to examine (1) the socio-demographic factors associated with RFUC and (2) which RFUC, among cannabis users, is associated with harmful patterns of cannabis use and with an increased risk for psychotic disorders.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample</head><p>This investigation is based on the European network of national schizophrenia networks studying Gene-Environment Interactions (EU-GEI study, <ref type="url" target="http://www.eu-gei.eu">http://www.eu-gei.eu</ref>), a multicentre incidence and case-sibling-control study of genetic and environmental determinants of psychotic disorder <ref type="bibr" target="#b26">(Gayer-Anderson et al., 2020;</ref><ref type="bibr" target="#b31">Jongsma et al., 2018)</ref> consisting of first-episode psychosis patients (FEPp) and population-based controls recruited between 2010 and 2015, who provided information on cannabis use <ref type="bibr" target="#b26">(Gayer-Anderson et al., 2020)</ref>. Both FEPp and controls were collected in 17 catchment areas in six countries: Southeast London, Cambridgeshire and Peterborough (England); central Amsterdam, Gouda and Voorhout (the Netherlands); part of the Veneto region, Bologna municipality, city of Palermo (Italy); 20th Arrondissement of Paris, Val-de-Marne, Puy-de-Dôme (France); Madrid (Vallecas), <ref type="bibr">Barcelona, Valencia, Oviedo, Santiago, Cuenca (Spain); and Ribeirão Preto (Brazil)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participants</head><p>All patients presenting with FEP who were referred to the mental healthcare services within the 17 catchment areas were identified by trained researchers. Patients were included in the current study if they were aged 18-64 years and resident within the study areas at the time of their first presentation and if they presented with a clinical diagnosis for an untreated FEP (International Statistical Classification of Diseases, Tenth Revision (ICD-10) codes F20-F33). Exclusion criteria were: (a) previous contact with psychiatric services for psychosis; (b) evidence of psychotic symptoms precipitated by an organic cause; and (c) transient psychotic symptoms resulting from acute intoxication, as defined by the ICD-10 (codes F1X.5). Controls were recruited using quota sampling based on local census data to ensure samples representativeness in each catchment area's population at risk in terms of age, gender, and ethnicity. Inclusion criteria for controls were: (a) aged between 18 and 64 years; (b) resident within the catchment areas at the time of consent into the study; (c) sufficient command of the primary language at each site to complete the assessments; and (d) no current or past psychotic disorder. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All participants who agreed to take part in the study provided informed, written consent; and ethical approval was provided by research ethics committees in each site: South  <ref type="bibr" target="#b26">(Gayer-Anderson et al., 2020)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measures and assessments</head><p>Data on age, gender, and self-reported ethnicity were collected using a modified version of the Medical Research Council Sociodemographic Schedule <ref type="bibr" target="#b37">(Mallett, Leff, Bhugra, Pang, &amp; Zhao, 2002)</ref>. Diagnoses of psychotic disorders were confirmed using the OPerational CRITeria (OPCRIT) system <ref type="bibr" target="#b41">(McGuffin, Farmer, &amp; Harvey, 1991;</ref><ref type="bibr" target="#b51">Williams, Farmer, Ackenheil, Kaufmann, &amp; McGuffin, 1996)</ref>, which was completed by centrally trained investigators whose inter-rater reliability was assessed throughout the study (κ = 0.7). Family history of mental illness and parental history of psychosis were collected using the Family Interview for Genetic Studies questionnaire <ref type="bibr" target="#b40">(Maxwell, 1992)</ref>. Finally, the Intelligence Quotient (IQ) score was derived using the short form of the WAIS-III (IQ), including selected items of the following subtests: digit symbol coding (a measure of processing speed), arithmetic (working memory), block design (visuospatial processing), and information (verbal knowledge) <ref type="bibr" target="#b49">(Tripoli et al., 2021)</ref>.</p><p>Detailed information on cannabis use was collected using the latest version of the Cannabis Experiences Questionnaire <ref type="bibr" target="#b9">(Barkus, Stirling, Hopkins, &amp; Lewis, 2006)</ref>, for the EU-GEI study (CEQ EU -GEI ). Consistently with Di Forti et al. ( <ref type="formula">2019</ref>), we used the combined measure of frequency and type of cannabis used derived from the following variables: (1) Frequency of use: never or occasional = 0, more than once a week = 1, daily = 2; (2) low potency cannabis with less than 10% of THC = 0, high potency THC 10% or greater = 1 (see online supplementary materials for a detailed description of this variable). This combined measure was used to define the harmful pattern of use and coded as follows: occasional use with any potency of use = 1, more than once a week and low potency = 2, more than once a week and high potency = 3, daily or almost and low potency = 4, daily or almost and high potency = 5 (see online supplementary). Age at first cannabis use was considered as a continuous numerical variable.</p><p>The information on RFUC was derived from the responses to the question 'why did you first try cannabis?' in the form of the following multiple-choice: (a) my friends were using it; (b) my family members were using it; (c) to feel better (to get relief from either physical or psychological discomfort) and (d) other. Subjects were able to provide up to 4 RFUC.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>We compared the number of different reported RFUC in cases and controls, also taking into account the overlapping answers.</p><p>T-test (Mann-Whitney where appropriate) and χ 2 in STATA16 were used to test for association between sociodemographics and IQ with RFUC. Only the variables associated with RFUC were included as covariates in the Path analyses.</p><p>We conducted unadjusted and adjusted logistic regressions using STATA-16 to examine whether RFUC was associated with FEP case-control status, adjusting for IQ score, gender, age at first cannabis use, ethnic minority status, and the harmful pattern of cannabis use. We conducted the analysis in stages to test four models. Model A examined the unadjusted associations between different RFUC and FEP case-control status. Model B examined the associations after adjusting for the harmful patterns of use. Model C additionally adjusted for age at first cannabis use. Lastly, model D additionally adjusted for ethnic minority status, IQ score, and gender. We compared the statistical fit of the four models using Log-Likelihood (LL), Akaike information criteria (AIC), and Bayesian information criteria (BIC).</p><p>Path analysis <ref type="bibr" target="#b48">(Stage, Carter, &amp; Nora, 2004</ref>) was run in STATA-16 to test the hypothesised direction in the relationship between multiple RFUC as predictors, with (1) pattern of cannabis use and (2) FEP case-control status.</p><p>In the regression analyses and in the path model, we included the participants who reported to have used cannabis either because of 'friends', 'family', or 'to feel better'.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Socio-demographic characteristics</head><p>Participants were recruited and consented to the study between May 1, 2010, and April 1, 2015. The 20th arrondissement of Paris was the only one that did not contribute to the recruitment of population controls; hence, it was excluded from the analyses. As in a previous EU-GEI paper <ref type="bibr" target="#b17">(Di Forti et al., 2019)</ref>, we also excluded Verona, Santiago, Oviedo, Valencia, and Cuenca because they had at least 10% of data missing on the measures of cannabis use. This left 901 FEPp and 1235 controls (see recruitment flow chart in the online supplementary materials).</p><p>585 FEPp (64.93%) and 574 (46.4%) of the controls reported lifetime cannabis use. Among these, 27 FEPp (4.62%) and 7 controls (1.22%) were excluded because of missing data on RFUC. Therefore, the sample resulted in a total size of 558 FEPp and 567 controls.</p><p>We found that, among users, 488 (86.1%) controls and 422 (75.63%) FEPp reported RFUC because of 'friends', while 38 (6.70%) controls and 69 (12.37%) FEPp reported RFUC because of their 'family' members; 33 (5.82%) controls and 112 (20.07%) of FEPp started 'to feel better', and 159 (28.04%) controls and 218 (39.07%) of FEPp because of 'other' reasons. See Fig. <ref type="figure" target="#fig_0">1</ref> for detailed information on the overlapping answers for this variable. Cannabis users who reported RFUC because of 'friends' did not show any association with the socio-demographic variables assessed. However, those who reported RFUC 'to feel better' were more often from ethnic minorities (χ 2 (1) = 13.67; p &lt; 0.001) and had lower IQ scores (U = 6.66; p &lt; 0.001). Similarly, those who reported RFUC because of their 'family' members, were more often from ethnic minorities (χ 2 (1) = 7.97; p = 0.005) and had lower IQ scores (U = 3.11; p = 0.002). Lastly, those who reported RFUC 'other' reasons were more likely to be male (χ 2 (1) = 8.65; p = 0.003) and were more often from ethnic minorities (χ 2 (1) = 4.43; p = 0.035; Table <ref type="table" target="#tab_1">1</ref>).</p><p>FEPp were more likely to belong to ethnic minority groups (χ 2 (1) = 62.37; p &lt; 0.001) and had lower IQ (U = 14.97; p &lt; 0.001) compared to controls (see online supplementary materials).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Logistic regressions</head><p>In the regression and in the path models, we included the participants who reported that they had used cannabis either because of 'friends', 'family', or 'to feel better', thus excluding 59 controls (10.41%) and 83 cases (14.87%) who reported 'other' as their RFUC. This resulted in a final sample of 475 FEPp and 508 controls with a complete dataset on reasons to start using cannabis.</p><p>The Model A unadjusted logistic regression indicated that RFUC because of 'friends' was negatively associated with being a FEP (OR 0.58; 95% CI 0.43-0.79), while those reporting RFUC because of 'family' members (OR 1.59; 95% CI 1.03-2.44) or 'to feel better' (OR 3.86; 95% CI 2.56-5.82) were more likely to become FEPp. In Model B, after controlling for the harmful patterns of use, RFUC because of 'family' members was no longer associated with FEP case-control status, while RFUC because of 'friends' was still associated with being a control (OR 0.64; 95% CI 0.45-0.91) and RFUC 'to feel better' was still associated with being a FEPp (OR 2.60; 95% CI 1.67-4.04). In Model C, after additionally adjusting for age at first cannabis use, the results remained consistent with Model B for both RFUC because of 'friends' (OR 0.62; 95% CI 0.44-0.88) and 'to feel better' (OR 2.63; 95% CI 1.69-4.10). In Model D, additionally adjusting for ethnic minority status, IQ score, and gender, RFUC because of 'friends' (OR 0.56; 95% CI 0.37-0.83) and 'to feel better' (OR 1.74; 95% CI 1.03-2.95) were still associated with FEP case-control status (See Table <ref type="table" target="#tab_2">2</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Path analysis</head><p>The path model had a good fit to the data: root mean square error of approximation (RMSEA) = 0.040, comparative fit index (CFI) = 0.99 (Fig. <ref type="figure" target="#fig_1">2</ref>). RFUC because of 'friends' was associated with being a control (β = -0.08; p = 0.002), while 'to feel better' was associated with being a FEPp (β = 0.07; p = 0.014) (see Table <ref type="table" target="#tab_3">3</ref> for direct associations). Lower IQ scores were indirectly associated with RFUC 'to feel better' (β = -0.19; p⩽0.001), with a younger age at first cannabis use (β = 0.11; p = 0.001), harmful pattern of cannabis use (β = -0.16; p⩽0.001) and were directly associated with being a FEPp (β = -0.36; p⩽0.001). On the contrary, higher IQ scores were associated with RFUC because of 'friends' (β = 0.07; p = 0.043), which was negatively associated with age at first cannabis use (β = -0.10; p = 0.002).</p><p>Both RFUC because of 'family' (β = 0.09; p = 0.003) and 'to feel better' (β = 0.15; p⩽0.001) were associated with a more harmful pattern of cannabis use, the latter also with being a FEPp. See Table <ref type="table" target="#tab_3">3</ref> for direct and indirect associations. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Psychological Medicine</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Principal findings</head><p>To the best of our knowledge (see online supplementary materials for details of literature search), this is the first study to examine what reasons underlie first using cannabis and if these reasons are associated with later pattern of cannabis use and the risk to develop a psychotic disorder. First, our findings indicate that having friends who use cannabis is the most common reason to start using cannabis among both those with FEPp and the controls; although, a higher proportion of FEPp than controls reported 'to feel better' as their RFUC (Fig. <ref type="figure" target="#fig_0">1</ref>). Second, we provide the first evidence that, (a) compared to those who RFUC with 'friends', those who reported starting 'to feel better' as their RFUC are much more likely to progress to daily use of high potency cannabis; and (b) those who started to use cannabis because of their 'friends' are more likely to have started their use earlier in their life (Table <ref type="table" target="#tab_3">3</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations and strengths</head><p>Our findings need to be appraised in the context of some limitations. Firstly, the data on cannabis use were collected retrospectively based on self-report. Therefore, they may be open to recall bias. However, studies comparing laboratory data and self-reported information have shown that cannabis users reliably report their frequency of use as well as the type of cannabis they use <ref type="bibr" target="#b11">(Buchan, Dennis, Tims, &amp; Diamond, 2002;</ref><ref type="bibr" target="#b25">Freeman et al., 2014)</ref>. While it is possible that FEPp are more likely, compared to controls, to retrospectively report 'to feel better' as a RFUC to justify their daily use leading to recall bias, the category 'to feel better' includes relief from both physical and psychological discomfort, therefore it is not intended to capture self-medication from prodromal symptoms. Moreover, a previous study has shown that cannabis use is associated with increased risk of psychosis even after adjustment for baseline prodromal symptoms <ref type="bibr" target="#b43">(Mustonen et al., 2018)</ref>. A recent study pointed out that some people might use cannabis to ameliorate anxiety and depressive symptoms <ref type="bibr" target="#b46">(Radhakrishnan et al., 2022)</ref>. However, the evidence suggests that cannabis use may increase the risk of developing depression and suicidality <ref type="bibr" target="#b27">(Gobbi et al., 2019)</ref>. A recent large online survey including responses from 27 169 participants from Canada and the USA, showed that 53% of people using cannabis to relieve physical discomfort reported using it to alleviate pain, followed by difficulties with sleep and headache/migraine as reasons to use <ref type="bibr" target="#b36">(Leung et al., 2022)</ref>. These are physical complaints persisting in nature and it is plausible that the attempt to alleviate them might lead to regular rather than occasional use.</p><p>Thirdly, although pathway analysis tests causal inferences and linkages among variables in the context of an a-priori conceptual model, causation cannot be implied. Despite the validity of path analysis in cross-sectional studies has been confirmed <ref type="bibr" target="#b19">(Etain et al., 2017;</ref><ref type="bibr" target="#b35">Kwok, Cheung, Jak, Ryu, &amp; Wu, 2018;</ref><ref type="bibr" target="#b39">Martin, 2011)</ref>, prospective longitudinal studies will be required to confirm   the detected associations, which nevertheless, in our study clearly places first use of cannabis on average at least a decade before the psychosis onset. Furthermore, this is a FEPp-control study which is less likely to lead to recall bias because the participants are recruited near the onset of their psychosis illness. Finally, the data presented here were collected from a control sample representative of each site's local population at risk <ref type="bibr" target="#b26">(Gayer-Anderson et al., 2020)</ref> and from a subset of FEPp representative of the larger incidence sample recruited from each site Mental Health services over the study period <ref type="bibr" target="#b31">(Jongsma et al., 2018)</ref>. Thus, our findings have the important strength of describing the RFUC reported by individuals with and without psychosis, from different ethnicities across different geographical areas and are therefore generalisable. Moreover, the use of matched controls might have masked the association between sociodemographic variables with RFUC and pattern of cannabis use.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparison with previous research</head><p>Previous research indicated that earlier age at first use is more likely to progress to longstanding use, resulting in overall greater exposure to cannabis <ref type="bibr" target="#b47">(Radhakrishnan, Wilkinson, &amp; D'Souza, 2014)</ref>. Furthermore, data have suggested that individuals who start using cannabis early in adolescence may be at most risk to develop psychotic disorder <ref type="bibr" target="#b8">(Arseneault et al., 2002;</ref><ref type="bibr" target="#b18">Dragt et al., 2010;</ref><ref type="bibr" target="#b34">Korver et al., 2010)</ref>; one study suggested they might 'selfmedicate' with cannabis to alleviate initial symptoms <ref type="bibr" target="#b20">(Ferdinand et al., 2005)</ref>. In contrast, our findings do not show an association between RFUC to 'feel better' and starting to use cannabis early in adolescence, which might be explained by our category 'to feel better' referring to relief not only of psychological but also physical discomfort. A recent study, in fact, shows how cannabis use for medical reasons is more common among young adults and older age groups rather than adolescence <ref type="bibr" target="#b36">(Leung et al., 2022)</ref>. Instead, we found that those who reported a younger age at first cannabis use were more likely to have started using cannabis 'with friends' compared to the other groups. This is in line with previous evidence looking at reasons to use cannabis which reports social context as the main reason for use <ref type="bibr" target="#b33">(Kolliakou et al., 2011)</ref>. The high number of cannabis users who start 'with friends' is in accord with previous findings indicating that cannabis users with psychosis have better premorbid social functioning compared to patients with psychosis not using cannabis <ref type="bibr" target="#b21">(Ferraro et al., 2021;</ref><ref type="bibr" target="#b22">Ferraro et al., 2020;</ref><ref type="bibr" target="#b23">Ferraro et al., 2013)</ref>. A possible explanation for this is that cannabis-using patients with psychosis are more socially skilled, and therefore able to obtain the substance than those who are neurodevelopmentally impaired <ref type="bibr" target="#b42">(Murray et al., 2017)</ref>. We found no evidence that those who report RFUC 'to feel better' are more likely to start using cannabis close to their age of psychosis onset.</p><p>RFUC because of 'family members' is associated with a more harmful pattern of use. This suggests that targeting the family environment could play an important role in delivering interventions for substance misuse and also to disseminate education messages about the risk associated with cannabis use and its harmful effects on mental health.</p><p>The existing evidence clearly indicates that daily use especially of high potency cannabis is robustly associated with an increased probability to develop a psychotic disorder <ref type="bibr" target="#b16">(Di Forti et al., 2009</ref><ref type="bibr" target="#b15">, 2015</ref><ref type="bibr">, 2019)</ref>. While we cannot separate those seeking relief from physical or psychological discomfort, our data suggest that starting to use cannabis 'to feel better' is more likely to progress to daily use of high potency cannabis and to later suffer a first episode psychosis.</p><p>In conclusion, while only a minority of cannabis users develops psychosis, understanding what drives people to first use cannabis can provide valuable data on (a) how to identify those more likely to develop a harmful pattern of use and design interventions for harm reduction or use cessation tailored to the individual's needs, (b) provide support and close monitoring to those using cannabis for medical reasons to minimise the risks associated with regular use, and (c) design better public health campaigns that are able to reach the individual in the social and family context where first use is most likely to begin.</p><p>Supplementary material. The supplementary material for this article can be found at <ref type="url" target="https://doi.org/10.1017/S0033291723001071">https://doi.org/10.1017/S0033291723001071</ref>.</p><p>Data. The data that support the findings of the study is available on request from the corresponding author, E.S.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. Overlapping reported RFUC in cases and controls.</figDesc><graphic coords="3,48.19,66.73,496.30,265.55" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. Direct and indirect pathways between IQ, ethnicity, RFUC and case-control status. Significant pathways signified by solid arrows and *; nonsignificant pathways represented by dotted lines. Model fit: χ 2 = 12.50, RMSEA = 0.040, comparative fit index CFI = 0.99..</figDesc><graphic coords="5,90.71,228.19,411.33,178.19" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc>Descriptive sociodemographic analyses based on reported RFUC (in cannabis users)</figDesc><table><row><cell>Statistics and</cell><cell>p value</cell><cell>χ 2 = 8.65</cell><cell>p = 0.003</cell><cell>χ 2 = 4.43</cell><cell>p = 0.035</cell><cell></cell><cell>χ 2 = 10.41</cell><cell>p = 0.034</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>U = 0.59</cell><cell>p = 0.56</cell><cell>χ = 0.36</cell><cell>p = 0.55</cell><cell>χ 2 = 0.75</cell><cell>p = 0.39</cell></row><row><cell>'Other' yes/no n</cell><cell>(% or SD)</cell><cell>257 (68.17)</cell><cell></cell><cell>122 (32.45)</cell><cell></cell><cell></cell><cell>254 (67.55)</cell><cell>48 (12.77)</cell><cell>42 (11.17)</cell><cell>13 (3.46)</cell><cell>19 (5.05)</cell><cell></cell><cell></cell><cell>96.35 (19.15)</cell><cell></cell><cell>132 (35.58)</cell><cell>31 (8.36)</cell></row><row><cell>Statistics and</cell><cell>p value</cell><cell>χ 2 = 1.58</cell><cell>p = 0.21</cell><cell>χ 2 = 13.67</cell><cell>p &lt; 0.001</cell><cell></cell><cell>χ 2 = 17.38</cell><cell>p = 0.002</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>U = 6.66</cell><cell>p &lt; 0.001</cell><cell>χ = 0.12</cell><cell>p = 0.73</cell><cell>χ 2 = 1.38</cell><cell>p = 0.24</cell></row><row><cell>'To feel better' yes/</cell><cell>no N (% or SD)</cell><cell>97 (66.90)</cell><cell></cell><cell>60 (41.38)</cell><cell></cell><cell></cell><cell>85 (58.62)</cell><cell>26 (17.93)</cell><cell>21 (14.48)</cell><cell>4 (2.76)</cell><cell>9 (6.21)</cell><cell></cell><cell></cell><cell>86.10 (17.25)</cell><cell></cell><cell>51 (35.66)</cell><cell>14 (9.79)</cell></row><row><cell>Statistics and</cell><cell>p value</cell><cell>χ 2 = 0.86</cell><cell>p = 0.35</cell><cell>χ 2 = 7.97</cell><cell>p = 0.005</cell><cell></cell><cell>χ 2 = 15.88</cell><cell>p = 0.003</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>U = 3.11</cell><cell>p = 0.002</cell><cell>χ = 1.28</cell><cell>0.26</cell><cell>χ 2 = 1.54</cell><cell>p = 0.21</cell></row><row><cell>'Family' yes/no N</cell><cell>(% or SD)</cell><cell>71 (66.36)</cell><cell></cell><cell>43 (40.19)</cell><cell></cell><cell></cell><cell>64 (59.81)</cell><cell>21 (19.63)</cell><cell>16 (14.95)</cell><cell>1 (0.93)</cell><cell>5 (4.67)</cell><cell></cell><cell></cell><cell>91.08 (19.89)</cell><cell></cell><cell>42 (39.25)</cell><cell>11 (10.28)</cell></row><row><cell>Statistics and</cell><cell>p value</cell><cell>χ 2 = 0.84</cell><cell>p = 0.36</cell><cell>χ 2 = 0.49</cell><cell>p = 0.48</cell><cell></cell><cell>χ 2 = 2.96</cell><cell>p = 0.57</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>U = -1.95</cell><cell>p = 0.051</cell><cell>χ = 0.02</cell><cell>p = 0.88</cell><cell>χ 2 = 0.68</cell><cell>p = 0.41</cell></row><row><cell>'Friends' yes/no N</cell><cell>(% or SD)</cell><cell>Gender Male 560 (61.54)</cell><cell></cell><cell>Ethnic Yes 254 (27.94)</cell><cell>minority</cell><cell>status</cell><cell>Ethnicity White 655 (72.06)</cell><cell cols="2">115 (12.65) Black 71 (7.81)</cell><cell cols="2">22 (2.42) Mixed 46 (5.06)</cell><cell>Asian</cell><cell>Other</cell><cell>IQ 97.30 (20.25)</cell><cell></cell><cell>Parental Yes 310 (34.33)</cell><cell>mental illness</cell><cell>Parental Yes 64 (7.09)</cell><cell>Psychosis</cell><cell>χ 2 , Chi-squared test; U, Mann-Whitney U test; *p-value ⩽ 0.05.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc>Unadjusted and adjusted associations between RFUC and case-control statusModel A: unadjusted associations; Model B: adjusted for harmful pattern of use; Model C: adjusted for harmful pattern of use and age at first cannabis use; Model D: adjusted for harmful pattern of use, age at first cannabis use, ethnic minority status, and IQ score.</figDesc><table><row><cell>Case-control outcome</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 .</head><label>3</label><figDesc>Panel A: Standardised Probit Coefficients (β) for the indirect pathways to psychosis with RFUC and pattern of cannabis use as mediators; Panel B Standardised Probit Coefficients (β) for the direct pathways to psychosis PANEL A. Indirect pathways to psychosis with RFUC and pattern of cannabis use as mediators</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="3">Via Frequency-potency of</cell></row><row><cell></cell><cell cols="2">Via Friends</cell><cell></cell><cell></cell><cell>Via Family</cell><cell></cell><cell></cell><cell>Via to feel better</cell><cell></cell><cell cols="3">Via Age at first cannabis use</cell><cell cols="2">cannabis use</cell><cell></cell></row><row><cell>Predictor variables</cell><cell>β</cell><cell>S.E.</cell><cell>p</cell><cell>β</cell><cell>S.E.</cell><cell>p</cell><cell>β</cell><cell>S.E.</cell><cell>p</cell><cell>β</cell><cell>S.E.</cell><cell>p</cell><cell>β</cell><cell>S.E.</cell><cell>p</cell></row><row><cell>IQ scores</cell><cell>0.07</cell><cell>0.03</cell><cell>0.043</cell><cell>-0.06</cell><cell>0.04</cell><cell>0.066</cell><cell>-0.19</cell><cell>0.03</cell><cell>&lt;0.001</cell><cell>0.11</cell><cell>0.03</cell><cell>0.001</cell><cell>-0.16</cell><cell>0.03</cell><cell>&lt;0.001</cell></row><row><cell>Ethnic minority Status</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>-0.05</cell><cell>0.03</cell><cell>0.12</cell><cell>0.03</cell><cell>0.03</cell><cell>0.336</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>0.07</cell><cell>0.03</cell><cell>0.025</cell></row><row><cell>Friends</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>-0.10</cell><cell>0.03</cell><cell>0.002</cell><cell>-0.09</cell><cell>0.03</cell><cell>0.002</cell></row><row><cell>Family</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>-0.02</cell><cell>0.03</cell><cell>0.49</cell><cell>0.09</cell><cell>0.03</cell><cell>0.003</cell></row><row><cell>To feel better</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>N/A</cell><cell>-0.04</cell><cell>0.03</cell><cell>0.209</cell><cell>0.15</cell><cell>0.03</cell><cell>&lt;0.001</cell></row><row><cell cols="2">PANEL B. Direct pathways to psychosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Case-control status</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Predictor variables</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>β</cell><cell></cell><cell></cell><cell></cell><cell>S.E.</cell><cell></cell><cell></cell><cell></cell><cell>p</cell><cell></cell><cell></cell></row><row><cell>IQ scores</cell><cell></cell><cell></cell><cell></cell><cell>-0.36</cell><cell></cell><cell></cell><cell></cell><cell>0.03</cell><cell></cell><cell></cell><cell></cell><cell>&lt;0.001</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Ethnic minority status</cell><cell></cell><cell></cell><cell></cell><cell>0.07</cell><cell></cell><cell></cell><cell></cell><cell>0.03</cell><cell></cell><cell></cell><cell></cell><cell>0.017</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Friends</cell><cell></cell><cell></cell><cell></cell><cell>-0.08</cell><cell></cell><cell></cell><cell></cell><cell>0.03</cell><cell></cell><cell></cell><cell></cell><cell>0.002</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Family</cell><cell></cell><cell></cell><cell></cell><cell>-0.003</cell><cell></cell><cell></cell><cell></cell><cell>0.03</cell><cell></cell><cell></cell><cell></cell><cell>0.913</cell><cell></cell><cell></cell><cell></cell></row><row><cell>To feel better</cell><cell></cell><cell></cell><cell></cell><cell>0.07</cell><cell></cell><cell></cell><cell></cell><cell>0.03</cell><cell></cell><cell></cell><cell></cell><cell>0.014</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Age at first cannabis use</cell><cell></cell><cell></cell><cell></cell><cell>-0.03</cell><cell></cell><cell></cell><cell></cell><cell>0.03</cell><cell></cell><cell></cell><cell></cell><cell>0.324</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Frequency-potency of cannabis use</cell><cell></cell><cell></cell><cell>0.25</cell><cell></cell><cell></cell><cell></cell><cell>0.29</cell><cell></cell><cell></cell><cell></cell><cell>&lt;0.001</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="5">Note: β, Probit coefficient; SE, Standard error; p, probability; N/A, Not applicable.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>https://doi.org/10.1017/S0033291723001071 Published online by Cambridge University Press</p></note>
		</body>
		<back>

			<div type="funding">
<div><p><rs type="person">Edoardo Spinazzola</rs> et al. <ref type="url" target="https://doi.org/10.1017/S0033291723001071">https://doi.org/10.1017/S0033291723001071</ref> Published online by <rs type="funder">Cambridge University Press</rs></p><p>Andreu-Bernabeu 3 , <rs type="person">Gonzalo López</rs> 3 , Mario Matteis 3 , Emiliano González 3 , <rs type="person">Manuel Durán-Cutilla 3</rs> , <rs type="person">Covadonga M. Díaz-Caneja 3</rs> , <rs type="programName">Pedro Cuadrado 4 , José Juan Rodríguez Solano 5 , Angel Carracedo 6 , Javier Costas 6 , Emilio Sánchez 7 , Silvia Amoretti 8 , Esther Lorente-Rovira 9</rs> , <rs type="person">Paz Garcia-Portilla 10</rs> , <rs type="person">Estela Jiménez-López 11</rs> , <rs type="person">Eva Velthorst 12</rs> , <rs type="programName">Nathalie Franke 12 , Daniella van Dam 12 , Fabian Termorshuizen 13</rs>,<rs type="grantNumber">14</rs> , <rs type="programName">Nathalie Franke 13 , Elsje van der Ven 13</rs>,<rs type="grantNumber">14</rs> , <rs type="person">Elles Messchaart 14</rs> , <rs type="person">Marion Leboyer 15</rs>,<rs type="grantNumber">16</rs>,17,18  , Franck Schürhoff 15,16,17,18  , Stéphane Jamain 16,17,18  , <rs type="person">Grégoire Baudin 15</rs>,<rs type="grantNumber">16</rs> , <rs type="person">Aziz Ferchiou 15</rs>,<rs type="grantNumber">16</rs> , <rs type="person">Baptiste Pignon 15</rs>,<rs type="grantNumber">16</rs>,<rs type="grantNumber">18</rs> , <rs type="person">Jean-Romain Richard</rs> <rs type="grantNumber">16</rs>,18 , Thomas Charpeaud 18,19,20  , Anne-Marie Tronche 18,19,20  , Pierre-Michel Llorca 20 , Flora Frijda 21,22 , <rs type="person">Giovanna Marrazzo 22</rs> , <rs type="person">Lucia Sideli 22</rs> , <rs type="person">Crocettarachele Sartorio 22</rs>,<rs type="grantNumber">23</rs> , <rs type="person">Fabio Seminerio 22</rs> , <rs type="person">Camila Marcelino Loureiro 24</rs>,<rs type="grantNumber">25</rs> , <rs type="person">Rosana Shuhama 24</rs>,<rs type="grantNumber">25</rs> , <rs type="person">Mirella Ruggeri 26</rs> , <rs type="person">Chiara Bonetto 26</rs> , <rs type="person">Doriana Cristofalo 26</rs> , <rs type="person">Domenico Berardi 27</rs> ,</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_YZ3KjTU">
					<orgName type="program" subtype="full">Pedro Cuadrado 4 , José Juan Rodríguez Solano 5 , Angel Carracedo 6 , Javier Costas 6 , Emilio Sánchez 7 , Silvia Amoretti 8 , Esther Lorente-Rovira 9</orgName>
				</org>
				<org type="funding" xml:id="_BcD34UD">
					<idno type="grant-number">14</idno>
					<orgName type="program" subtype="full">Nathalie Franke 12 , Daniella van Dam 12 , Fabian Termorshuizen 13</orgName>
				</org>
				<org type="funding" xml:id="_6uBNMJS">
					<idno type="grant-number">14</idno>
					<orgName type="program" subtype="full">Nathalie Franke 13 , Elsje van der Ven 13</orgName>
				</org>
				<org type="funding" xml:id="_QPEtz8M">
					<idno type="grant-number">16</idno>
				</org>
				<org type="funding" xml:id="_d55GMvN">
					<idno type="grant-number">16</idno>
				</org>
				<org type="funding" xml:id="_STpVHcB">
					<idno type="grant-number">16</idno>
				</org>
				<org type="funding" xml:id="_BYsvQNY">
					<idno type="grant-number">16</idno>
				</org>
				<org type="funding" xml:id="_FB3cc6p">
					<idno type="grant-number">18</idno>
				</org>
				<org type="funding" xml:id="_eQ7Y8gC">
					<idno type="grant-number">16</idno>
				</org>
				<org type="funding" xml:id="_UBe9djh">
					<idno type="grant-number">23</idno>
				</org>
				<org type="funding" xml:id="_Ny6FYRT">
					<idno type="grant-number">25</idno>
				</org>
				<org type="funding" xml:id="_kAvshUz">
					<idno type="grant-number">25</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Author contributions. E. S., D. Q., V. R., M. D. F., and R. M. contributed to the conceptualization and design of the study. E. S., D. Q., M. D. F., and R. M. took part in the interpretation of the data and wrote the first draft. All other authors contributed to the revision of the manuscript. They also read and approved the final manuscript. Conflict of interest. J Bobes has received research grants and served as consultant, advisor or speaker for AB-Biotics, Acadia Pharmaceuticals, Ambrosseti-Angelini, Casen Recordati, D&amp;A Pharma, Exeltis, Gilead, Indivior, Janssen-Cilag, Lundbeck, Mundipharma, Otsuka, Pfizer, Roche, Sage Therapeutics, Servier, Schwabe Farma Ibérica, Shire, Takeda, research funding from the Spanish Ministry of Economy and Competiveness -Centro de Investigación Biomedica en Red area de Salud Mental (CIBERSAM) and Instituto de Salud Carlos III-, Spanish Ministry of Health, Social Services and Equality -Plan Nacional sobre Drogas outside of the submitted work. M Bernardo has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of AB-Biotics, Adamed, Angelini, Casen Recordati, Janssen-Cilag, Menarini, Rovi and Takeda. C Arango reports personal fees from Acadia, Ambrosseti, Gedeon Richter, Janssen Cilag, Lundbeck, Merck, Otsuka, Roche, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda; and grants from CIBERSAM, Familia Alonso, Fundacion Alicia Koplowitz, the European Commission, the Spanish Ministry of Science and Universities, and the Comunidad de Madrid, during the conduct of the study. PB Jones reports personal fees from being a member of the scientific advisory boards for Janssen and Ricordati, outside of the submitted work. Prof Michael O' Donovan is supported by a collaborative research grant from Takeda outside of the submitted work. R M Murray reports personal fees from Janssen, Lundbeck, Sunovion, and Otsuka, outside of the submitted work. M Di Forti reports personal fees from Janssen, outside the submitted work. All other authors declare no competing interests.</p><p>EU-GEI Collaborators. Kathryn Hubbard 1 , Stephanie Beards 1 , Simona A. Stilo 2 , Mara Parellada 3 , David Fraguas 3 , Marta Rapado Castro 3 , Álvaro</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Via G. La Loggia</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">90129</biblScope>
		</imprint>
		<respStmt>
			<orgName>of Experimental Biomedicine and Clinical Neuroscience, Section of Psychiatry, University of Palermo</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Italy</forename><surname>Palermo</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<author>
			<persName><forename type="first">"</forename><forename type="middle">P</forename><surname>Unit Of Psychiatry</surname></persName>
		</author>
		<author>
			<persName><surname>Giaccone</surname></persName>
		</author>
		<title level="m">General Hospital, Via G. La Loggia n</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">90129</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m" type="main">24 Departamento de Neurociências e Ciencias do Comportamento</title>
		<author>
			<persName><forename type="first">Italy</forename><surname>Palermo</surname></persName>
		</author>
		<idno>3900 -Monte Alegre-CEP 14049-900</idno>
		<imprint>
			<pubPlace>Ribeirão Preto, SP, Brasil</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Av. Bandeirantes</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">27 Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna</title>
	</analytic>
	<monogr>
		<title level="m">28 Division of Psychological Medicine and Clinical Neurosciences</title>
		<meeting><address><addrLine>Ribeirão Preto, SP, Brasil; Verona, Italy; Bologna, Italy; Cardiff, UK.</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">10</biblScope>
		</imprint>
		<respStmt>
			<orgName>Núcleo de Pesquina em Saúde Mental Populacional, Universidade de São Paulo ; Department of Neuroscience, Biomedicine and Movement, University of Verona ; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University</orgName>
		</respStmt>
	</monogr>
	<note>Avenida Doutor Arnaldo 455, CEP 01246-903</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">King&apos;s College of London</title>
		<author>
			<orgName type="collaboration">2 Social</orgName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King&apos;s College</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<pubPlace>London, UK; King&apos;s College London, London SE5 8AF, UK; London, UK</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience ; Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience ; National Institute for Health Research</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Service of General Psychiatry, Treatment and Early Intervention in Psychosis Program</title>
		<author>
			<persName><forename type="first">South</forename><surname>London</surname></persName>
			<affiliation>
				<orgName type="collaboration">IBIS</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">Nhs</forename><surname>Maudsley</surname></persName>
			<affiliation>
				<orgName type="collaboration">IBIS</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mental Health Foundation Trust</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<pubPlace>London, UK; Lausanne, University Hospital (CHUV), Lausanne, Switzerland; Sevilla, Spain</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Universitario Virgen del Rocio, Departamento de Psiquiatria, Universidad de Sevilla</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Department of Psychiatry, Servicio de Psiquiatría Hospital &quot;Virgen de la Luz</title>
	</analytic>
	<monogr>
		<title level="m">Etablissement Public de Sante Maison Blanche</title>
		<meeting><address><addrLine>London, UK; London, UK; St. Louis, MO, USA; Crotone, Italy; Verona, Italy; Bologna, Italy; Creteil, France; Paris, France; Monza, Italy; Lecco, Italy; Rome, Italy; Leiden, The Netherlands; Maastricht, The Netherlands; AZ Amsterdam, The Netherlands; São Paulo, Brazil; Cuenca, Spain; Santiago, Spain; Oviedo, Spain; Valencia, Spain</addrLine></address></meeting>
		<imprint>
			<publisher>King&apos;s College London</publisher>
			<date type="published" when="1105">1105</date>
			<biblScope unit="volume">11</biblScope>
		</imprint>
		<respStmt>
			<orgName>Biomedicine, Neuroscience and Advanced Diagnostic Department, Psychiatry Section, University of Palermo, Palermo, Italy; 8 Department of Health Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience ; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK; 10 National Addiction Centre, Institute of Psychiatry, King&apos;s College London ; Department of Psychiatry, Washington University School of Medicine ; Psylife Group, Division of Psychiatry, University College London, London, UK; 13 Department of Mental Health and Addiction Services, ASP Crotone ; Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona ; Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum Università di Bologna ; Department of Medicine and Surgery, University of Milano Bicocca ; Sapienza University of Rome ; Rivierduinen Institute for Mental Health Care ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre ; Early Psychosis Section, AmsterdamUMC, Academic Medical Centre, University of Amsterdam ; Department of Preventive Medicine, Faculdade de Medicina, Universidade of São Paulo ; Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela ; Department of Medicine, Psychiatry Area, School of Medicine, Universidad de Oviedo, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) ; Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) ; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona</orgName>
		</respStmt>
	</monogr>
	<note>Department of Neurosciences, Mental Health and Sensory Organs. Institut d&apos;Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Biomedical Research Networking Centre in Mental Health (CIBERSAM), References</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Arseneault</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cannon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Poulton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Caspi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Moffitt</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.325.7374.1212</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="1212" to="1213" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Cannabis-induced psychosis-like experiences are associated with high schizotypy</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Barkus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stirling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Hopkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lewis</surname></persName>
		</author>
		<idno type="DOI">10.1159/000092678</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopathology</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="175" to="178" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Differences in cannabis-related experiences between patients with a first episode of psychosis and controls</title>
		<author>
			<persName><forename type="first">F</forename><surname>Bianconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bonomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kolliakou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Stilo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Iyegbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<idno type="DOI">10.1017/S0033291715002494</idno>
	</analytic>
	<monogr>
		<title level="j">Psychological Medicine</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="995" to="1003" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Buchan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Tims</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Diamond</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1360-0443.97.s01.1.x</idno>
	</analytic>
	<monogr>
		<title level="m">Cannabis use; consistency and validity of self-report, on-site urine testing and laboratory testing</title>
		<imprint>
			<date type="published" when="2002">2002</date>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="98" to="108" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: Psychometric analysis of the obsessive compulsive drug use scale</title>
		<author>
			<persName><forename type="first">N</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koeter</surname></persName>
		</author>
		<author>
			<persName><surname>Van Den</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Brink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Investigators</surname></persName>
		</author>
		<idno type="DOI">10.1002/mpr.1362</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Methods in Psychiatric Research</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="286" to="300" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders</title>
		<author>
			<persName><forename type="first">N</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Linszen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Haan</surname></persName>
		</author>
		<idno type="DOI">10.1159/000236906</idno>
	</analytic>
	<monogr>
		<title level="j">Psychopathology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="350" to="360" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls</title>
		<author>
			<persName><forename type="first">N</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Smeerdijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Wiers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Duits</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Van Gelder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Houben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Haan</surname></persName>
		</author>
		<idno type="DOI">10.1017/S0033291709991814</idno>
	</analytic>
	<monogr>
		<title level="j">Psychological Medicine</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1325" to="1336" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Proportion of patients in south London with firstepisode psychosis attributable to use of high potency cannabis: A case-control study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Carra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fraietta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Trotta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bonomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Murray</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2215-0366(14)00117-5</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="233" to="238" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">High-potency cannabis and the risk of psychosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dazzan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pariante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Mondelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Marques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Murray</surname></persName>
		</author>
		<idno type="DOI">10.1192/bjp.bp.109.064220</idno>
	</analytic>
	<monogr>
		<title level="j">The British Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="488" to="491" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Quattrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tripoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gayer-Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Quigley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Der Ven</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2215-0366(19)30048-3</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="427" to="436" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Dragt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Nieman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Van De Fliert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Dingemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Haan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Linszen</surname></persName>
		</author>
		<idno type="DOI">10.1177/070674371005500308</idno>
	</analytic>
	<monogr>
		<title level="j">Canadian Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="165" to="171" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Revisiting the association between childhood trauma and psychosis in bipolar disorder: A quasi-dimensional path-analysis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Etain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lajnef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bellivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>M'bailara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fisher</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpsychires.2016.09.022</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Psychiatric Research</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="73" to="79" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cannabis use predicts future psychotic symptoms, and vice versa</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Ferdinand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sondeijker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Der Ende</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Selten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Huizink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Verhulst</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1360-0443.2005.01070.x</idno>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="612" to="618" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ferraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>La Cascia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>La Barbera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sanchez-Gutierrez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tripoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Seminerio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Quattrone</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.schres.2021.08.008</idno>
	</analytic>
	<monogr>
		<title level="j">Schizophrenia Research</title>
		<imprint>
			<biblScope unit="volume">236</biblScope>
			<biblScope unit="page" from="69" to="79" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Premorbid adjustment and IQ in patients with firstepisode psychosis: A multisite case-control study of their relationship with cannabis use</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ferraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>La Cascia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Quattrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sideli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Matranga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Capuccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<idno type="DOI">10.1093/schbul/sbz077</idno>
	</analytic>
	<monogr>
		<title level="j">Schizophrenia Bulletin</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="517" to="529" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Cannabis users have higher premorbid IQ than other patients with first onset psychosis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ferraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>O'connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Wiffen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Falcone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sideli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.schres.2013.07.046</idno>
	</analytic>
	<monogr>
		<title level="j">Schizophrenia Research</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="129" to="135" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Craft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stylianou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Elsohly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Lynskey</surname></persName>
		</author>
		<idno type="DOI">10.1111/add.15253</idno>
	</analytic>
	<monogr>
		<title level="m">Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: Systematic review and meta-analysis</title>
		<imprint>
			<date type="published" when="2021">2021</date>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="1000" to="1010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Just say &apos;know&apos;: How do cannabinoid concentrations influence users&apos; estimates of cannabis potency and the amount they roll in joints?</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hindocha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schafer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Das</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">V</forename><surname>Curran</surname></persName>
		</author>
		<idno type="DOI">10.1111/add.12634</idno>
	</analytic>
	<monogr>
		<title level="j">Addiction</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="1686" to="1694" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The European network of national schizophrenia networks studying gene-environment interactions (EU-GEI): Incidence and first-episode case-control programme</title>
		<author>
			<persName><forename type="first">C</forename><surname>Gayer-Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Jongsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Quattrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Velthorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Haan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morgan</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00127-020-01831-x</idno>
	</analytic>
	<monogr>
		<title level="j">Social Psychiatry and Psychiatric Epidemiology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="645" to="657" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Gobbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Atkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zytynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Askari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boruff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mayo</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamapsychiatry.2018.4500</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA Psychiatry</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="426" to="434" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Reasons for cannabis use in men with and without psychosis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Kavanagh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Young</surname></persName>
		</author>
		<idno type="DOI">10.1080/09595230412331324563</idno>
	</analytic>
	<monogr>
		<title level="j">Drug and Alcohol Review</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="445" to="453" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hjorthoj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S K</forename><surname>Starzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nordentoft</surname></persName>
		</author>
		<idno type="DOI">10.1017/S0033291719003532</idno>
	</analytic>
	<monogr>
		<title level="j">Psychological Medicine</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="617" to="622" />
			<date type="published" when="2016">2021a. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Development over time of the population-attributable risk fraction for cannabis use disorder in schizophrenia in Denmark</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hjorthoj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Posselt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nordentoft</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamapsychiatry.2021.1471</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA Psychiatry</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="1013" to="1019" />
			<date type="published" when="2021">2021b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">… European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package, G</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Jongsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gayer-Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lasalvia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Quattrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Szoke</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamapsychiatry.2017.3554</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA Psychiatry</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="36" to="46" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>Treated incidence of psychotic disorders in the multinational EU-GEI study</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Khantzian</surname></persName>
		</author>
		<idno type="DOI">10.1176/ajp.142.11.1259</idno>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="1259" to="1264" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Why do patients with psychosis use cannabis and are they ready to change their use?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kolliakou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Joseph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ismail</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Atakan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Murray</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijdevneu.2010.11.006</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Developmental Neuroscience</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="335" to="346" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls</title>
		<author>
			<persName><forename type="first">N</forename><surname>Korver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Nieman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Van De Fliert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Dingemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Haan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Linszen</surname></persName>
		</author>
		<idno type="DOI">10.3109/00048670903487118</idno>
	</analytic>
	<monogr>
		<title level="j">Australian &amp; New Zealand Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="230" to="236" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Recent advancements in structural equation modeling (sem): From both methodological and application perspectives</title>
		<author>
			<persName><forename type="first">O.-M</forename><surname>Kwok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-Y</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.3389/fpsyg.2018.01936</idno>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Psychology</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<date type="published" when="1936">2018. 1936</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Prevalence and self-reported reasons of cannabis use for medical 7426 Edoardo Spinazzola et</title>
		<author>
			<persName><forename type="first">J</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stjepanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y C</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hammond</surname></persName>
		</author>
		<idno type="DOI">10.1017/S0033291723001071</idno>
		<idno>doi:10.1007/s00213-021-06047-8</idno>
		<ptr target="https://doi.org/10.1017/S0033291723001071" />
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology (Berl)</title>
		<imprint>
			<biblScope unit="volume">239</biblScope>
			<biblScope unit="page" from="1509" to="1519" />
			<date type="published" when="2022">2022</date>
			<publisher>Cambridge University Press purposes in USA and Canada</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Social environment, ethnicity and schizophrenia. A case-control study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mallett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bhugra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Zhao</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00127-002-0557-4</idno>
	</analytic>
	<monogr>
		<title level="j">Social Psychiatry and Psychiatric Epidemiology</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="329" to="335" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Meta-analysis of the association between the level of cannabis use and risk of psychosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Marconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vassos</surname></persName>
		</author>
		<idno type="DOI">10.1093/schbul/sbw003</idno>
	</analytic>
	<monogr>
		<title level="j">Schizophrenia Bulletin</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1262" to="1269" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Prescriptive statements and educational practice: What can structural equation modeling (SEM) offer?</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10648-011-9160-0</idno>
	</analytic>
	<monogr>
		<title level="j">Educational Psychology Review</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="235" to="244" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Family interview for genetic studies (FIGS): A manual for FIGS</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Maxwell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Neurogenetics Branch</title>
		<imprint>
			<date type="published" when="1992">1992</date>
			<pubPlace>Bethesda, MD</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Intramural Research Program, National Institute of Mental Health</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">A polydiagnostic application of operational criteria in studies of psychotic illness: Development and reliability of the OPCRIT system</title>
		<author>
			<persName><forename type="first">P</forename><surname>Mcguffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Harvey</surname></persName>
		</author>
		<idno type="DOI">10.1001/archpsyc.1991.01810320088015</idno>
	</analytic>
	<monogr>
		<title level="j">Archives of General Psychiatry</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="764" to="770" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Cannabis-associated psychosis: Neural substrate and clinical impact</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Englund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abi-Dargham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>… D'souza</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuropharm.2017.06.018</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="89" to="104" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mustonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Niemelä</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nordström</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mäki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jääskeläinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miettunen</surname></persName>
		</author>
		<idno type="DOI">10.1192/bjp.2017.52</idno>
	</analytic>
	<monogr>
		<title level="j">The British Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="227" to="233" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Reasons and subjective effects of cannabis use among people with psychotic disorders: A systematic review</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Pérez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Santacana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Baquero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pérez-Solà</surname></persName>
		</author>
		<ptr target="https://pubmed.ncbi.nlm.nih.gov/24715366/" />
	</analytic>
	<monogr>
		<title level="j">Acta Espanolas de Psiquiatria</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="83" to="90" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Subjective effects of cannabis before the first psychotic episode</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>De Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Dingemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Linszen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Haan</surname></persName>
		</author>
		<idno type="DOI">10.3109/00048670903179095</idno>
	</analytic>
	<monogr>
		<title level="j">Australian and New Zealand Journal of Psychiatry</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1115" to="1162" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: Further support for an affective pathway to psychosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Radhakrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Pries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Erzin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ten Have</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Dorsselaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guloksuz</surname></persName>
		</author>
		<idno type="DOI">10.1017/S0033291722002756</idno>
	</analytic>
	<monogr>
		<title level="j">Psychological Medicine</title>
		<imprint>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Gone to Pot -A review of the association between cannabis and psychosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Radhakrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Wilkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Souza</surname></persName>
		</author>
		<idno type="DOI">10.3389/fpsyt.2014.00054</idno>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Psychiatry</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">54</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Path analysis: An introduction and analysis of a decade of research</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Stage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nora</surname></persName>
		</author>
		<idno type="DOI">10.3200/joer.98.1.5-13</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Educational Research</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="5" to="13" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Tripoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Quattrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ferraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gayer-Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>La Cascia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Forti</surname></persName>
		</author>
		<idno type="DOI">10.1017/S003329171900357X</idno>
	</analytic>
	<monogr>
		<title level="j">Psychological Medicine</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="623" to="633" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Schizophrenia and the environment: Within-person analyses may be required to yield evidence of unconfounded and causal association-The example of cannabis and psychosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Van Os</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Pries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ten Have</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Dorsselaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guloksuz</surname></persName>
		</author>
		<idno type="DOI">10.1093/schbul/sbab019</idno>
	</analytic>
	<monogr>
		<title level="j">Schizophrenia Bulletin</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="594" to="603" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system</title>
		<author>
			<persName><forename type="first">J</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ackenheil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Kaufmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mcguffin</surname></persName>
		</author>
		<idno type="DOI">10.1017/s003329170003779x</idno>
	</analytic>
	<monogr>
		<title level="j">Psychological Medicine</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="775" to="783" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
